Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Biochem Pharmacol. 2022 Apr 4;200:115028. doi: 10.1016/j.bcp.2022.115028

Figure 6: Proposed binding mode of pimavanserin at 5-HT2A (light green) and 5-HT2CRs (dark green).

Figure 6:

Molecular docking and molecular dynamics simulations indicate that pimavanserin engages nearly identical amino acid residues within the binding pocket of 5-HT2A and 5-HT2CRs. The primary determinant of selectivity, the extension of the isobutoxybenzyl moiety into the side-extended cavity between TM4 and TM5 (purple circle), as allowed by the small side chain of G5.42, is conserved in both receptors and is accompanied by a raised rotamer conformation of F5.38 in both receptor subtypes.